Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COBALT: Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation

NCT02431988 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT02431988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02431988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COBALT: Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation
Lead sponsor
University College, London
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2016
Completion date
March 21, 2022
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b-cell lymphoma